{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:31:01Z","timestamp":1794047461524,"version":"4.8.0"},"reference-count":60,"publisher":"Ferrata Storti Foundation (Haematologica)","issue":"8","license":[{"start":{"date-parts":[[2024,1,18]],"date-time":"2024-01-18T00:00:00Z","timestamp":1705536000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["haematol"],"abstract":"<jats:p>D-2-hydroxyglutarate (D-2-HG) accumulates in patients with acute myeloid leukemia (AML) with mutated isocitrate dehydrogenase (IDH) and in other malignancies. D-2-HG suppresses antitumor T-cell immunity but little is known about potential effects on non-malignant myeloid cells. Here we show that D-2-HG impairs human but not murine dendritic cell differentiation, resulting in a tolerogenic phenotype with low major histocompatibility class II expression. In line with this, IDH-mutated AML blasts exhibited lower expression of HLA-DP and were less susceptible to lysis by HLA-DP-specific T cells. Interestingly, besides its expected impact on DNA demethylation, D-2-HG reprogrammed metabolism towards increased lactate production in dendritic cells and AML. Vitamin C accelerated DNA demethylation, but only the combination of vitamin C and glycolytic inhibition lowered lactate levels and supported major histocompatibility complex class II expression. Our results indicate an unexpected link between the immunosuppressive metabolites 2-HG and lactic acid and suggest a potentially novel therapeutic strategy with combinations of anti-glycolytic drugs and epigenetic modulators (hypomethylating agents) or other therapeutics for the treatment of AML.<\/jats:p>","DOI":"10.3324\/haematol.2023.283597","type":"journal-article","created":{"date-parts":[[2024,1,18]],"date-time":"2024-01-18T03:48:50Z","timestamp":1705549730000},"page":"2500-2514","source":"Crossref","is-referenced-by-count":7,"title":["D-2-hydroxyglutarate supports a tolerogenic phenotype with lowered major histocompatibility class II expression in non-malignant dendritic cells and acute myeloid leukemia cells"],"prefix":"10.3324","volume":"109","author":[{"given":"Kathrin","family":"Hammon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathrin","family":"Renner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Althammer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Voll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Babl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonja-Maria","family":"Decking","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter J.","family":"Siska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carina","family":"Matos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zugey Elizabeth C\u00e1rdenas","family":"Conejo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karina","family":"Mendes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Friederike","family":"Einwag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heiko","family":"Siegmund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Iberl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaela S.","family":"Berger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katja","family":"Dettmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Schoenmehl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Brochhausen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Herr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter J.","family":"Oefner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Rehli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Kreutz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1856","published-online":{"date-parts":[[2024,1,18]]},"reference":[{"key":"64302","doi-asserted-by":"crossref","unstructured":"Dang L, Yen K, Attar EC. IDH mutations in cancer and progress toward development of targeted therapeutics. Ann Oncol. 2016; 27(4):599-608.","DOI":"10.1093\/annonc\/mdw013"},{"key":"64303","doi-asserted-by":"crossref","unstructured":"Molenaar RJ, Radivoyevitch T, Maciejewski JP, van Noorden CJF, Bleeker FE. The driver and passenger effects of isocitrate dehydrogenase 1 and 2 mutations in oncogenesis and survival prolongation. Biochim Biophys Acta. 2014; 1846(2):326-341.","DOI":"10.1016\/j.bbcan.2014.05.004"},{"key":"64304","doi-asserted-by":"crossref","unstructured":"Dang L, White DW, Gross S. Cancer-associated IDH1 mutations produce 2-hydroxyglutarate. Nature. 2009; 462(7274):739-744.","DOI":"10.1038\/nature08617"},{"key":"64305","doi-asserted-by":"crossref","unstructured":"Janin M, Mylonas E, Saada V. Serum 2-hydroxyglutarate production in IDH1- and IDH2-mutated de novo acute myeloid leukemia: a study by the Acute Leukemia French Association group. J Clin Oncol. 2014; 32(4):297-305.","DOI":"10.1200\/JCO.2013.50.2047"},{"key":"64306","doi-asserted-by":"crossref","unstructured":"Terunuma A, Putluri N, Mishra P. MYC-driven accumulation of 2-hydroxyglutarate is associated with breast cancer prognosis. J Clin Invest. 2014; 124(1):398-412.","DOI":"10.1172\/JCI71180"},{"key":"64307","doi-asserted-by":"crossref","unstructured":"Shim E-H, Livi CB, Rakheja D. L-2-hydroxyglutarate: an epigenetic modifier and putative oncometabolite in renal cancer. Cancer Discov. 2014; 4(11):1290-1298.","DOI":"10.1158\/2159-8290.CD-13-0696"},{"key":"64308","doi-asserted-by":"crossref","unstructured":"Ye D, Guan K-L, Xiong Y. Metabolism, activity, and targeting of D-and L-2-hydroxyglutarates. Trends Cancer. 2018; 4(2):151-165.","DOI":"10.1016\/j.trecan.2017.12.005"},{"key":"64309","doi-asserted-by":"crossref","unstructured":"Waitkus MS, Diplas BH, Yan H. Biological role and therapeutic potential of IDH mutations in cancer. Cancer Cell. 2018; 34(2):186-195.","DOI":"10.1016\/j.ccell.2018.04.011"},{"key":"64310","doi-asserted-by":"crossref","unstructured":"Figueroa ME, Abdel-Wahab O, Lu C. Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation. Cancer Cell. 2010; 18(6):553-567.","DOI":"10.1016\/j.ccr.2010.11.015"},{"key":"64311","doi-asserted-by":"crossref","unstructured":"Chaturvedi A, Araujo Cruz MM, Jyotsana N. Mutant IDH1 promotes leukemogenesis in vivo and can be specifically targeted in human AML. Blood. 2013; 122(16):2877-2887.","DOI":"10.1182\/blood-2013-03-491571"},{"key":"64312","doi-asserted-by":"crossref","unstructured":"Losman J-A, Looper RE, Koivunen P. (R)-2-hydroxyglutarate is sufficient to promote leukemogenesis and its effects are reversible. Science. 2013; 339(6127):1621-1625.","DOI":"10.1126\/science.1231677"},{"key":"64313","doi-asserted-by":"crossref","unstructured":"Tyrakis PA, Palazon A, Macias D. S-2-hydroxyglutarate regulates CD8+ T-lymphocyte fate. Nature. 2016; 540(7632):236-241.","DOI":"10.1038\/nature20165"},{"key":"64314","doi-asserted-by":"crossref","unstructured":"Bunse L, Pusch S, Bunse T. Suppression of antitumor T cell immunity by the oncometabolite (R)-2-hydroxyglutarate. Nat Med. 2018; 24(8):1192-1203.","DOI":"10.1038\/s41591-018-0095-6"},{"key":"64315","doi-asserted-by":"crossref","unstructured":"Friedrich M, Sankowski R, Bunse L. Tryptophan metabolism drives dynamic immunosuppressive myeloid states in IDH-mutant gliomas. Nat Cancer. 2021; 2(7):723-740.","DOI":"10.1038\/s43018-021-00201-z"},{"key":"64316","doi-asserted-by":"crossref","unstructured":"Zhang L, Sorensen MD, Kristensen BW, Reifenberger G, McIntyre TM, Lin F. D-2-hydroxyglutarate is an intercellular mediator in IDH-mutant gliomas inhibiting complement and T cells. Clin Cancer Res. 2018; 24(21):5381-5391.","DOI":"10.1158\/1078-0432.CCR-17-3855"},{"key":"64317","doi-asserted-by":"crossref","unstructured":"Lutz MB, Kukutsch N, Ogilvie AL. An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J Immunol Methods. 1999; 223(1):77-92.","DOI":"10.1016\/S0022-1759(98)00204-X"},{"key":"64318","doi-asserted-by":"crossref","unstructured":"Rai G, Brimacombe KR, Mott BT. Discovery and optimization of potent, cell-active pyrazole-based inhibitors of lactate dehydrogenase (LDH). J Med Chem. 2017; 60(22):9184-9204.","DOI":"10.1021\/acs.jmedchem.7b00941"},{"key":"64319","doi-asserted-by":"crossref","unstructured":"Thomas S, Klobuch S, Besold K. Strong and sustained effector function of memory- versus na\u00efve-derived T cells upon T-cell receptor RNA transfer: implications for cellular therapy. Eur J Immunol. 2012; 42(12):3442-3453.","DOI":"10.1002\/eji.201242666"},{"key":"64320","doi-asserted-by":"crossref","unstructured":"Gnaiger E, Steinlechner-Maran R, M\u00e9ndez G, Eberl T, Margreiter R. Control of mitochondrial and cellular respiration by oxygen. J Bioenerg Biomembr. 1995; 27(6):583-596.","DOI":"10.1007\/BF02111656"},{"key":"64321","doi-asserted-by":"crossref","unstructured":"Grassinger J, Khomenko A, Hart C. Safety and feasibility of long term administration of recombinant human granulocyte-colony stimulating factor in patients with amyotrophic lateral sclerosis. Cytokine. 2014; 67(1):21-28.","DOI":"10.1016\/j.cyto.2014.02.003"},{"key":"64322","doi-asserted-by":"crossref","unstructured":"Klug M, Schmidhofer S, Gebhard C, Andreesen R, Rehli M. 5-Hydroxymethylcytosine is an essential intermediate of active DNA demethylation processes in primary human monocytes. Genome Biol. 2013; 14(5):R46.","DOI":"10.1186\/gb-2013-14-5-r46"},{"key":"64323","doi-asserted-by":"crossref","unstructured":"Ugele I, C\u00e1rdenas-Conejo ZE, Hammon K. D-2-hydroxyglutarate and L-2-hydroxyglutarate inhibit IL-12 secretion by human monocyte-derived dendritic cells. Int J Mol Sci. 2019; 20(3):742.","DOI":"10.3390\/ijms20030742"},{"key":"64324","doi-asserted-by":"crossref","unstructured":"Pearce EJ, Everts B. Dendritic cell metabolism. Nat Rev Immunol. 2015; 15(1):18-29.","DOI":"10.1038\/nri3771"},{"key":"64325","doi-asserted-by":"crossref","unstructured":"Reinfeld BI, Madden MZ, Wolf MM. Cell-programmed nutrient partitioning in the tumour microenvironment. Nature. 2021; 593(7858):282-288.","DOI":"10.1038\/s41586-021-03442-1"},{"key":"64326","doi-asserted-by":"crossref","unstructured":"Shim H, Dolde C, Lewis BC. c-Myc transactivation of LDH-A: implications for tumor metabolism and growth. Proc Natl Acad Sci U S A. 1997; 94(13):6658-6663.","DOI":"10.1073\/pnas.94.13.6658"},{"key":"64327","doi-asserted-by":"crossref","unstructured":"Boudreau A, Purkey HE, Hitz A. Metabolic plasticity underpins innate and acquired resistance to LDHA inhibition. Nat Chem Biol. 2016; 12(10):779-786.","DOI":"10.1038\/nchembio.2143"},{"key":"64328","doi-asserted-by":"crossref","unstructured":"Gottfried E, Kunz-Schughart LA, Ebner S. Tumor-derived lactic acid modulates dendritic cell activation and antigen expression. Blood. 2006; 107(5):2013-2021.","DOI":"10.1182\/blood-2005-05-1795"},{"key":"64329","doi-asserted-by":"crossref","unstructured":"Laghmouchi A, Hoogstraten C, van Balen P, Falkenburg JHF, Jedema I. The allogeneic HLA-DP-restricted T-cell repertoire provoked by allogeneic dendritic cells contains T cells that show restricted recognition of hematopoietic cells including primary malignant cells. Haematologica. 2019; 104(1):197-206.","DOI":"10.3324\/haematol.2018.193680"},{"key":"64330","doi-asserted-by":"crossref","unstructured":"Herr W, Eichinger Y, Beshay J. HLA-DPB1 mismatch alleles represent powerful leukemia rejection antigens in CD4 T-cell immunotherapy after allogeneic stem-cell transplantation. Leukemia. 2017; 31(2):434-445.","DOI":"10.1038\/leu.2016.210"},{"key":"64331","doi-asserted-by":"crossref","unstructured":"Klobuch S, Hammon K, Vatter-Leising S. HLA-DPB1 reactive T cell receptors for adoptive immunotherapy in allogeneic stem cell transplantation. Cells. 2020; 9(5):1264.","DOI":"10.3390\/cells9051264"},{"key":"64332","doi-asserted-by":"crossref","unstructured":"Blaschke K, Ebata KT, Karimi MM. Vitamin C induces Tet-dependent DNA demethylation and a blastocyst-like state in ES cells. Nature. 2013; 500(7461):222-226.","DOI":"10.1038\/nature12362"},{"key":"64333","doi-asserted-by":"crossref","unstructured":"Gerecke C, Schumacher F, Berndzen A, Homann T, Kleuser B. Vitamin C in combination with inhibition of mutant IDH1 synergistically activates TET enzymes and epigenetically modulates gene silencing in colon cancer cells. Epigenetics. 2020; 15(3):307-322.","DOI":"10.1080\/15592294.2019.1666652"},{"key":"64334","doi-asserted-by":"crossref","unstructured":"Fu X, Chin RM, Vergnes L. 2-Hydroxyglutarate inhibits ATP synthase and mTOR signaling. Cell Metab. 2015; 22(3):508-515.","DOI":"10.1016\/j.cmet.2015.06.009"},{"key":"64335","doi-asserted-by":"crossref","unstructured":"K\u00f6lker S, Pawlak V, Ahlemeyer B. NMDA receptor activation and respiratory chain complex V inhibition contribute to neurodegeneration in d-2-hydroxyglutaric aciduria. Eur J Neurosci. 2002; 16(1):21-28.","DOI":"10.1046\/j.1460-9568.2002.02055.x"},{"key":"64336","doi-asserted-by":"crossref","unstructured":"Chan SM, Thomas D, Corces-Zimmerman MR. Isocitrate dehydrogenase 1 and 2 mutations induce BCL-2 dependence in acute myeloid leukemia. Nat Med. 2015; 21(2):178-184.","DOI":"10.1038\/nm.3788"},{"key":"64337","doi-asserted-by":"crossref","unstructured":"B\u00f6ttcher M, Renner K, Berger R. D-2-hydroxyglutarate interferes with HIF-1\u03b1 stability skewing T-cell metabolism towards oxidative phosphorylation and impairing Th17 polarization. Oncoimmunology. 2018; 7(7):e1445454.","DOI":"10.1080\/2162402X.2018.1445454"},{"key":"64338","doi-asserted-by":"crossref","unstructured":"Stuani L, Sabatier M, Saland E. Mitochondrial metabolism supports resistance to IDH mutant inhibitors in acute myeloid leukemia. J Exp Med. 2021; 218(5):e20200924.","DOI":"10.1084\/jem.20200924"},{"key":"64339","doi-asserted-by":"crossref","unstructured":"Navis AC, Niclou SP, Fack F. Increased mitochondrial activity in a novel IDH1-R132H mutant human oligodendroglioma xenograft model: in situ detection of 2-HG and \u03b1-KG. Acta Neuropathol Commun. 2013; 1:18.","DOI":"10.1186\/2051-5960-1-18"},{"key":"64340","doi-asserted-by":"crossref","unstructured":"Qing Y, Dong L, Gao L. R-2-hydroxyglutarate attenuates aerobic glycolysis in leukemia by targeting the FTO\/m6A\/PFKP\/ LDHB axis. Mol Cell. 2021; 81(5):922-939.e9.","DOI":"10.1016\/j.molcel.2020.12.026"},{"key":"64341","doi-asserted-by":"crossref","unstructured":"Chesnelong C, Chaumeil MM, Blough MD. Lactate dehydrogenase A silencing in IDH mutant gliomas. Neuro Oncol. 2014; 16(5):686-695.","DOI":"10.1093\/neuonc\/not243"},{"key":"64342","doi-asserted-by":"crossref","unstructured":"Guak H, Al Habyan S, Ma EH. Glycolytic metabolism is essential for CCR7 oligomerization and dendritic cell migration. Nat Commun. 2018; 9(1):2463.","DOI":"10.1038\/s41467-018-04804-6"},{"key":"64343","doi-asserted-by":"crossref","unstructured":"Goetzman ES, Prochownik EV. The role for Myc in coordinating glycolysis, oxidative phosphorylation, glutaminolysis, and fatty acid metabolism in normal and neoplastic tissues. Front Endocrinol (Lausanne). 2018; 9:129.","DOI":"10.3389\/fendo.2018.00129"},{"key":"64344","doi-asserted-by":"crossref","unstructured":"Oktay Y, \u00dclgen E, Can \u00d6. IDH-mutant glioma specific association of rs55705857 located at 8q24.21 involves MYC deregulation. Sci Rep. 2016; 6:27569.","DOI":"10.1038\/srep27569"},{"key":"64345","doi-asserted-by":"crossref","unstructured":"Williams NC, Ryan DG, Costa ASH. Signaling metabolite L-2-hydroxyglutarate activates the transcription factor HIF-1\u03b1 in lipopolysaccharide-activated macrophages. J Biol Chem. 2022; 298(2):101501.","DOI":"10.1016\/j.jbc.2021.101501"},{"key":"64346","doi-asserted-by":"crossref","unstructured":"Garc\u00eda-Gonz\u00e1lez PA, Maggi J, Schinnerling K. Regulation of tolerogenic features on dexamethasone-modulated MPLA-activated dendritic cells by MYC. Front Immunol. 2019; 10:1171.","DOI":"10.3389\/fimmu.2019.01171"},{"key":"64347","doi-asserted-by":"crossref","unstructured":"Qiu Z, Lin A-P, Jiang S. MYC regulation of D2HGDH and L2HGDH influences the epigenome and epitranscriptome. Cell Chem Biol. 2020; 27(5):538-550.","DOI":"10.1016\/j.chembiol.2020.02.002"},{"key":"64348","doi-asserted-by":"crossref","unstructured":"Cui B, Luo Y, Tian P. Stress-induced epinephrine enhances lactate dehydrogenase A and promotes breast cancer stem-like cells. J Clin Invest. 2019; 129(3):1030-1046.","DOI":"10.1172\/JCI121685"},{"key":"64349","doi-asserted-by":"crossref","unstructured":"God JM, Cameron C, Figueroa J. Elevation of c-MYC disrupts HLA class II-mediated immune recognition of human B cell tumors. J Immunol. 2015; 194(4):1434-1445.","DOI":"10.4049\/jimmunol.1402382"},{"key":"64350","doi-asserted-by":"crossref","unstructured":"Masuda K, Hiraki A, Fujii N. Loss or down-regulation of HLA class I expression at the allelic level in freshly isolated leukemic blasts. Cancer Sci. 2007; 98(1):102-108.","DOI":"10.1111\/j.1349-7006.2006.00356.x"},{"key":"64351","doi-asserted-by":"crossref","unstructured":"Christopher MJ, Petti AA, Rettig MP. Immune escape of relapsed AML cells after allogeneic transplantation. N Engl J Med. 2018; 379(24):2330-2341.","DOI":"10.1056\/NEJMoa1808777"},{"key":"64352","doi-asserted-by":"crossref","unstructured":"Kohanbash G, Carrera DA, Shrivastav S. Isocitrate dehydrogenase mutations suppress STAT1 and CD8+ T cell accumulation in gliomas. J Clin Invest. 2017; 127(4):1425-1437.","DOI":"10.1172\/JCI90644"},{"key":"64353","doi-asserted-by":"crossref","unstructured":"Kadiyala P, Carney SV, Gauss JC. Inhibition of 2-hydroxyglutarate elicits metabolic reprogramming and mutant IDH1 glioma immunity in mice. J Clin Invest. 2021; 131(4):e139542.","DOI":"10.1172\/JCI139542"},{"key":"64354","doi-asserted-by":"crossref","unstructured":"Fleischhauer K, Shaw BE. HLA-DP in unrelated hematopoietic cell transplantation revisited: challenges and opportunities. Blood. 2017; 130(9):1089-1096.","DOI":"10.1182\/blood-2017-03-742346"},{"key":"64355","doi-asserted-by":"crossref","unstructured":"Toffalori C, Zito L, Gambacorta V. Immune signature drives leukemia escape and relapse after hematopoietic cell transplantation. Nat Med. 2019; 25(4):603-611.","DOI":"10.1038\/s41591-019-0400-z"},{"key":"64356","doi-asserted-by":"crossref","unstructured":"Chen W-L, Wang J-H, Zhao A-H. A distinct glucose metabolism signature of acute myeloid leukemia with prognostic value. Blood. 2014; 124(10):1645-1654.","DOI":"10.1182\/blood-2014-02-554204"},{"key":"64357","doi-asserted-by":"crossref","unstructured":"Uhl FM, Chen S, O\u2019Sullivan D. Metabolic reprogramming of donor T cells enhances graft-versus-leukemia effects in mice and humans. Sci Transl Med. 2020; 12(567):eabb8969.","DOI":"10.1126\/scitranslmed.abb8969"},{"key":"64358","doi-asserted-by":"crossref","unstructured":"Turner TB, Meza-Perez S, Londo\u00f1o A. Epigenetic modifiers upregulate MHC II and impede ovarian cancer tumor growth. Oncotarget. 2017; 8(27):44159-44170.","DOI":"10.18632\/oncotarget.17395"},{"key":"64359","doi-asserted-by":"crossref","unstructured":"Chen Q, Espey MG, Krishna MC. Pharmacologic ascorbic acid concentrations selectively kill cancer cells: action as a pro-drug to deliver hydrogen peroxide to tissues. Proc Natl Acad Sci U S A. 2005; 102(38):13604-13609.","DOI":"10.1073\/pnas.0506390102"},{"key":"64360","doi-asserted-by":"crossref","unstructured":"Molenaar RJ, Botman D, Smits MA. Radioprotection of IDH1-mutated cancer cells by the IDH1-mutant inhibitor AGI-5198. Cancer Res. 2015; 75(22):4790-4802.","DOI":"10.1158\/0008-5472.CAN-14-3603"},{"key":"64361","doi-asserted-by":"crossref","unstructured":"Molenaar RJ, Radivoyevitch T, Nagata Y. IDH1\/2 mutations sensitize acute myeloid leukemia to PARP inhibition and this is reversed by IDH1\/2-mutant inhibitors. Clin Cancer Res. 2018; 24(7):1705-1715.","DOI":"10.1158\/1078-0432.CCR-17-2796"}],"container-title":["Haematologica"],"original-title":[],"link":[{"URL":"https:\/\/haematologica.org\/article\/download\/haematol.2023.283597\/76501","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/haematologica.org\/article\/download\/haematol.2023.283597\/77342","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/haematologica.org\/article\/download\/11409\/76501","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:05:33Z","timestamp":1794045933000},"score":1,"resource":{"primary":{"URL":"https:\/\/haematologica.org\/article\/view\/haematol.2023.283597"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,18]]},"references-count":60,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2024,8,1]]}},"URL":"https:\/\/doi.org\/10.3324\/haematol.2023.283597","relation":{},"ISSN":["1592-8721","0390-6078"],"issn-type":[{"value":"1592-8721","type":"electronic"},{"value":"0390-6078","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1,18]]}}}